Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Qantas monitors brainwaves of pilots and passengers to test 19.5‑hour flight from NY to Sydney

Mon­i­tor­ing brain­waves via dreem wer­able device (Qan­tas)

_______________

Qan­tas’ first 19.5‑hour research flight from New York to Syd­ney takes off (Nine News):

Qan­tas CEO Alan Joyce, who today is in New York for the research flight, told Today Show via a live cross that he will be select­ing an air­craft for the mam­moth job by the year’s end, in line with a pre­vi­ous time-line.

The flight is going to be ground-break­ing, as you said. We’ve got 19 hours — we’ve got a lot of sci­en­tists and we’re look­ing at dif­fer­ent ways of mak­ing the oper­a­tion actu­al­ly great for our pas­sen­gers,” Joyce said. Read the rest of this entry »

Update: 200 common prescription medications increase depression risk

___

Dear read­er,

Time for Sharp­Brains e‑newsletter.

It’s been a busy month, once again bring­ing to the fore­front the lim­i­ta­tions of our cur­rent health­care sys­tem and, on the pos­i­tive side, the grow­ing oppor­tu­ni­ties to improve Brain Health and Men­tal Health for all, if we pay atten­tion to (and act on) lat­est research, think­ing and tools.

New tools:

 

Final­ly, we invite you to tease your mind with these four opti­cal illu­sions. Sur­pris­ing, aren’t they?

Have a great month of July,

 

The Sharp­Brains Team

Sleep-focused neurotech firm Dreem raises $35M from Johnson&Johnson Innovation and Bpifrance

___

Dreem Announces $35 Mil­lion Financ­ing from lead investors John­son & John­son Inno­va­tion and Bpifrance (press release):

Dreem, a neu­rotech­nol­o­gy com­pa­ny, today announced the clos­ing of a new round of fund­ing, rais­ing $35 mil­lion USD to rapid­ly accel­er­ate prod­uct devel­op­ment, invest in strate­gic research and devel­op­ment, and advance the future of sleep tech­nol­o­gy. Last year, Dreem intro­duced a com­pre­hen­sive solu­tion to address a suite of sleep prob­lems and Read the rest of this entry »

Neurotech start-up Rythm raises $11 million more to develop and commercialize sleep-monitoring headband Dreem

Dreem machine: Rythm rais­es $11 mil­lion and launch­es $500 sleep-mon­i­tor­ing head­band (Ven­ture­Beat)

Found­ed out of France in 2014, Rythm is now based in San Fran­cis­co, where it has been work­ing toward bring­ing its Dreem machine head­band to market…In a nut­shell, Rythm touts itself as a neu­rotech­nol­o­gy com­pa­ny that’s set­ting out to “enhance” your sleep, Read the rest of this entry »

French neurotech start-up Rythm raises $11m to help improve sleep quality

Rythm dreem—–

Rythm rais­es $11M to pur­sue sleep-improv­ing neu­rotech­nol­o­gy (TechCrunch):

French start­up Rythm, which makes a tech-infused head­set it claims improves sleep qual­i­ty, announced Tues­day that it’s raised over $11 mil­lion from pri­vate investors and pub­lic grants Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

twitter_logo_header
RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.